Display options
Share it on

Indian J Endocrinol Metab. 2016 Jul-Aug;20(4):491-6. doi: 10.4103/2230-8210.183469.

Comparison of maternal and fetal outcomes among Asian Indian pregnant women with or without gestational diabetes mellitus: A situational analysis study (WINGS-3).

Indian journal of endocrinology and metabolism

Manni Mohanraj Mahalakshmi, Balaji Bhavadharini, Kumar Maheswari, Gunasekaran Kalaiyarasi, Ranjit Mohan Anjana, Unnikrishnan Ranjit, Viswanathan Mohan, Kurian Joseph, Kurian Rekha, Sivagnanam Nallaperumal, Belma Malanda, Arivudainambi Kayal, Anne Belton, Ram Uma

Affiliations

  1. Department of Epidemiology and Diabetology, Madras Diabetes Research Foundation, Chennai, Tamil Nadu, India.
  2. Department of Obstetrics and Gynecology, Joseph Nursing Home, Chennai, Tamil Nadu, India.
  3. Department of Diabetology, Prashanth Infertility Research Centre, Chennai, Tamil Nadu, India.
  4. Department of Policy and Programmes, International Diabetes Federation, Brussels, Belgium.
  5. Department of Obstetrics and Gynecology, Seethapathy Clinic and Hospital, Chennai, Tamil Nadu, India.

PMID: 27366715 PMCID: PMC4911838 DOI: 10.4103/2230-8210.183469

Abstract

AIM: To compare the existing maternal and fetal outcomes in Asian Indian women with or without gestational diabetes mellitus (GDM) before the development of the Women in India with GDM Strategy (WINGS) GDM model of care (MOC).

MATERIALS AND METHODS: Records of pregnant women were extracted retrospectively from three maternity centers in Chennai. GDM was diagnosed using the International Association for Pregnancy Study Groups criteria or the Carpenter and Coustan criteria. Demographic details, obstetric history, antenatal follow-up, treatment for GDM, and outcomes of delivery were collected from the electronic medical records.

RESULTS: Of the 3642 records analyzed, 799 (21.9%) had GDM, of whom 456 (57.1%) were treated with insulin and medical nutrition therapy (MNT), 339 (42.4%) with MNT alone, and 4 (0.5%) with metformin. Women with GDM were older than those without (28.5 ± 4.5 vs. 27.1 ± 4.5 years; P < 0.001) and had higher mean body mass index at first booking (26.4 ± 5.2 kg/m(2) vs. 25.2 ± 5.1 kg/m(2); P < 0.001). Rates of cesarean section (26.2% vs. 18.7%; P < 0.001), preeclampsia (1.8% vs. 0.8%; P = 0.04), and macrosomia (13.9% vs. 10.8%; P = 0.02) were significantly higher among women with GDM. In women with GDM treated with insulin and MNT, emergency cesarean section (16.2% vs. 36.6%; P < 0.0001), preeclampsia (0.7% vs. 3.2%; P = 0.015), and macrosomia (9.9% vs. 18.6%; P = 0.0006) were significantly lesser compared to those treated with MNT alone.

CONCLUSION: Pregnancy outcomes were in general worse in GDM women. Treatment with insulin was associated with a significantly lower risk of complications. However, in countries with limited access to insulin and other medicines may lead to poor follow-up and management of GDM. Data from this retrospective study will form the basis for the development of the WINGS GDM MOC, which will address these gaps in GDM care in low-resource settings.

Keywords: Asian Indians; South Asians; fetal outcomes; gestational diabetes mellitus; maternal outcomes

References

  1. Int J Gynaecol Obstet. 2001 Dec;75(3):221-8 - PubMed
  2. Eur J Obstet Gynecol Reprod Biol. 2002 Apr 10;102(1):36-41 - PubMed
  3. Neonatal Netw. 2001 Sep;20(6):17-23 - PubMed
  4. J Matern Fetal Neonatal Med. 2002 Dec;12(6):362-4 - PubMed
  5. Braz J Med Biol Res. 2003 Oct;36(10):1297-300 - PubMed
  6. Am Fam Physician. 2003 Nov 1;68(9):1767-72 - PubMed
  7. N Engl J Med. 2005 Jun 16;352(24):2477-86 - PubMed
  8. Diabetes. 1991 Dec;40 Suppl 2:79-82 - PubMed
  9. Diabetes Care. 2007 Jul;30 Suppl 2:S251-60 - PubMed
  10. N Engl J Med. 2008 May 8;358(19):1991-2002 - PubMed
  11. Int J Gynaecol Obstet. 2009 Mar;104 Suppl 1:S25-6 - PubMed
  12. Int J Gynaecol Obstet. 2009 Mar;104 Suppl 1:S35-8 - PubMed
  13. Diabetes Educ. 1991 Nov-Dec;17(6):435 - PubMed
  14. Diabetes Care. 2010 Jan;33 Suppl 1:S11-61 - PubMed
  15. Indian J Med Sci. 2009 Nov;63(11):491-7 - PubMed
  16. J Matern Fetal Neonatal Med. 2010 Mar;23(3):196-8 - PubMed
  17. Diabetes Care. 2010 Mar;33(3):676-82 - PubMed
  18. Acta Obstet Gynecol Scand. 2011 Mar;90(3):231-7 - PubMed
  19. Birth. 2011 Jun;38(2):142-9 - PubMed
  20. J Womens Health (Larchmt). 2011 Sep;20(9):1333-9 - PubMed
  21. Diabetes Res Clin Pract. 2012 Dec;98(3):396-405 - PubMed
  22. Diabetol Metab Syndr. 2012 Dec 02;4(1):50 - PubMed
  23. Eur J Endocrinol. 2015 Aug;173(2):257-67 - PubMed
  24. J Postgrad Med. 2015 Jul-Sep;61(3):155-8 - PubMed
  25. Indian J Endocrinol Metab. 2016 May-Jun;20(3):364-8 - PubMed
  26. Indian J Endocrinol Metab. 2016 Sep-Oct;20(5):707-715 - PubMed
  27. Am J Obstet Gynecol. 1989 Oct;161(4):981-6 - PubMed
  28. Obstet Gynecol. 1985 Aug;66(2):158-61 - PubMed
  29. Am J Obstet Gynecol. 1984 Dec 1;150(7):836-42 - PubMed
  30. Am J Obstet Gynecol. 1995 Jul;173(1):146-56 - PubMed
  31. Am J Obstet Gynecol. 1995 Feb;172(2 Pt 1):607-14 - PubMed
  32. Diabetes Care. 1994 Apr;17(4):275-83 - PubMed
  33. Am J Obstet Gynecol. 1977 Mar 1;127(5):465-9 - PubMed
  34. JAMA. 1996 Apr 17;275(15):1165-70 - PubMed
  35. Obstet Gynecol. 1997 Dec;90(6):869-73 - PubMed
  36. Diabetes Care. 1998 Aug;21 Suppl 2:B113-7 - PubMed

Publication Types